Zurück zu Projekte

15610.1 PFLS-LS

15610.1 PFLS-LS

Zusammenfassung

Development of a recently validated cell penetrating peptide into an efficacious therapeutic cancer vaccine

Weitere Texte

Abstract

Therapeutic cancer vaccines are becoming an attractive approach that can be combined with standard of care to treat cancer patients. The patient immune system is educated to specifically recognize and destroy tumor cells. This project aims at designing and optimizing an immunization strategy for a new cancer vaccine including the vector, the antigen and the choice of adjuvant. Finally, the proof-of-concept will be performed in a murine model of brain tumors.

Beteiligte

Madiha Derouazi

Wirtschaftspartner

madiha.derouazi@amaltherapeutics.com

Amal Therapeutics SA Madiha Derouazi Avenue de la Roseraie 64 1205 Genève GE CH

Paul Walker

Kontaktperson

Paul.Walker@hcuge.ch

Université de Genève Paul Walker Rue Gabrielle-Perret-Gentil 4 1211 Genève GE CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2013-07-31
Enddatum
2015-10-31
Bewilligte Gesamtkosten
CHF 488704.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Industrielle Produktivität und Technologie

Forschungsdisziplinen

  • T490 Biotechnology 100.0%